WebDyne Therapeutics has 5 employees at their 1 location and $165 m in total funding,. See insights on Dyne Therapeutics including office locations, competitors, revenue, … WebNov 3, 2024 · Cash position: Cash, cash equivalents and marketable securities were $248.1 million as of September 30, 2024, which is anticipated to fund operations through 2024. Research and development (R&D) expenses: R&D expenses were $34.7 million for the quarter ended September 30, 2024, compared to $36.5 million for the quarter ended …
Dyne Therapeutics Announces Initiation of Phase 1/2 ACHIEVE …
WebMar 30, 2024 · 85.5% of Dyne Therapeutics shares are held by institutional investors. 43.7% of Precigen shares are held by insiders. Comparatively, 42.3% of Dyne … WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's email format. ... Dyne Therapeutics Top Competitors. Company Employees Revenue Top technologies; Akouos. 57: $19.2 M: Generation Bio. 106: $18.5 M: Leap Therapeutics. … nordstrom rack tv commercial
Dyne Therapeutics NasdaqGS:DYN Stock Report - Simply Wall St
WebApr 11, 2024 · Dyne Therapeutics has a 52-week low of $4.30 and a 52-week high of $15.63. Dyne Therapeutics ( NASDAQ:DYN - Get Rating ) last issued its quarterly earnings data on Thursday, March 2nd. The company reported ($0.74) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.84) by $0.10. WebDyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for … WebOct 2, 2024 · Dyne Therapeutics Competitors. There are no companies similar to Dyne Therapeutics Dyne Therapeutics Related Companies. ... No industry vertical has been recorded for Dyne Therapeutics View All. Dyne Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. 19 companies. how to remove food grease stain from shirt